Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Chemoradiation for anal cancer: the more things change, the more they stay the same.

Fuller CD, Thomas CR Jr.

Oncology (Williston Park). 2010 Apr 30;24(5):427-30. No abstract available.

2.

Optimizing outcomes of chemoradiation in the management of squamous cell carcinoma of the anal canal.

McHaffie DR, Kozak KR.

Oncology (Williston Park). 2010 Apr 30;24(5):424-7. No abstract available.

3.

HIV-associated anal squamous cell cancer: an otherwise preventable disease.

Konstantinopoulos PA, Schlecht HP, Bryan B, Pantanowitz L, Dezube BJ.

J Clin Oncol. 2006 Sep 20;24(27):4516-7. No abstract available.

PMID:
16983122
4.

Preoperative radio-chemotherapy in anal carcinoma.

Denecke H, Roloff R.

Recent Results Cancer Res. 1988;110:134-9. No abstract available.

PMID:
3136517
5.

[Radiotherapy of epidermoid cancers of the anal canal].

Schlienger M.

Ann Gastroenterol Hepatol (Paris). 1991 May;27(3):125-31. French. No abstract available.

PMID:
1715137
6.

Bilateral leg amputation following chemoradiation for squamous carcinoma of the anus.

Evans TK, Phillips HA.

Radiother Oncol. 2004 Oct;73(1):110-1. No abstract available.

PMID:
15465156
7.

Efficacy and toxicity of chemoradiation in the treatment of HIV-associated anal cancer.

Hauerstock D, Ennis RD, Grossbard M, Evans A.

Clin Colorectal Cancer. 2010 Oct;9(4):238-42. doi: 10.3816/CCC.2010.n.035.

PMID:
20920996
8.

Anal cancer treatment: current status and future perspectives.

Ghosn M, Kourie HR, Abdayem P, Antoun J, Nasr D.

World J Gastroenterol. 2015 Feb 28;21(8):2294-302. doi: 10.3748/wjg.v21.i8.2294. Review.

9.

[Management of anal canal carcinoma].

Thang NN, Cochet S, George AC, Betz M, Roth A.

Rev Med Suisse. 2011 May 25;7(296):1144-8. Review. French.

PMID:
21721205
10.

[Concurrent radiochemotherapy with 5-FU/mitomycin remains standard treatment for anal carcinoma. Long-term results of the phase III RTOG 98-11 trial].

Nieder C.

Strahlenther Onkol. 2013 Jun;189(6):512-3. doi: 10.1007/s00066-013-0335-0. German. No abstract available.

PMID:
23609134
11.

Management of anal cancer in 2010. Part 2: current treatment standards and future directions.

Abbas A, Yang G, Fakih M.

Oncology (Williston Park). 2010 Apr 30;24(5):417-24. Review.

12.

Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.

Eng C, Chang GJ, You YN, Das P, Xing Y, Delclos M, Wolff RA, Rodriguez-Bigas MA, Skibber J, Ohinata A, Gould S, Phillips J, Crane CH.

Cancer. 2013 Nov 1;119(21):3769-75. doi: 10.1002/cncr.28296. Epub 2013 Aug 20.

13.

[A case of a geriatric patient with stage IV anal canal cancer showing complete response to chemoradiation therapy].

Kuroda M, Hirai R, Ikeda E, Tsuji H, Takagi S, Yamano T, Yoshitomi S.

Gan To Kagaku Ryoho. 2012 Nov;39(12):1926-8. Japanese.

PMID:
23267932
14.

Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy.

Doyen J, Benezery K, Follana P, Ortholan C, GĂ©rard JP, Hannoun-Levi JM, Gal J, Francois E.

Dis Colon Rectum. 2013 Oct;56(10):1125-33. doi: 10.1097/DCR.0b013e3182a226bd.

PMID:
24022529
15.

Squamous cell carcinoma of the anal margin: the university of Florida experience.

Balamucki CJ, Zlotecki RA, Rout WR, Newlin HE, Morris CG, Kirwan JM, George TJ Jr, Mendenhall WM.

Am J Clin Oncol. 2011 Aug;34(4):406-10. doi: 10.1097/COC.0b013e3181e9c0c0.

PMID:
20881476
16.

Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal.

Jaiyesimi IA, Pazdur R.

Am J Clin Oncol. 1993 Dec;16(6):536-40. No abstract available.

PMID:
8256774
17.

Management of anal cancer in the HIV-positive population.

Kauh J, Koshy M, Gunthel C, Joyner MM, Landry J, Thomas CR Jr.

Oncology (Williston Park). 2005 Nov;19(12):1634-8; discussion 1638-40, 1645 passim. Review.

18.

Advances in the Management of Anal Cancer.

Julie DR, Goodman KA.

Curr Oncol Rep. 2016 Mar;18(3):20. doi: 10.1007/s11912-016-0503-3. Review.

PMID:
26905274
19.

Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.

Hung A, Crane C, Delclos M, Ballo M, Ajani J, Lin E, Feig B, Skibber J, Janjan N.

Cancer. 2003 Mar 1;97(5):1195-202.

20.

[Three cases of radiotherapy combined with S-1 and mitomycin C for anal canal squamous cell carcinomas].

Shiozawa M, Nishimura K, Nonaka T, Yoshii T, Nakayama N, Motohashi O, Takagi S, Nakayama Y, Akaike M.

Gan To Kagaku Ryoho. 2010 Dec;37(13):2941-3. Japanese.

PMID:
21160276

Supplemental Content

Support Center